Pill risk perspective
Dr Terri Foran examines the evidence for the associated risk of venous thromboembolism with the combined oral contraceptive pill.
In recent months there has been a flurry of litigation in the US and Canada related to venous thromboembolism occurring in users of combined oral contraception pills (COCPs) that contain the newer progestogens, such as drospirenone.
One of the problems with the associated media coverage is that following such reports, some women may simply stop using their contraceptive method without consulting their doctor for advice.
Delays in restarting alternative preparations and a general undermining of confidence in the safety of hormonal contraception saw a significant increase in the number of unintended pregnancies in the months following the alert. In the UK in the following year, deliveries increased by 25% and terminations rose by 9% —